Specialty Enzymes Market by Source (Microorganism, Plant, Animal), Type (Carbohydrases, Proteases, Lipases, Polymerases & Nucleases), Application (Pharmaceuticals, Diagnostics, Research & Biotechnology), Form & Region - Global Forecast to 2029
According to MarketsandMarkets, the global Specialty enzymes market size is estimated to be valued at USD 6.1 billion in 2024 and is projected to reach USD 9.2 billion by 2029, recording a CAGR of 8.5%, during the forecast period in terms of value. Their ability to cleave complex carbohydrates on biomolecules holds immense potential for developing highly specific diagnostic tools. For instance, carbohydrases can be used to target specific sugar signatures on pathogens, enabling rapid and accurate identification of infectious diseases. Additionally, they can be employed to analyze specific carbohydrate markers associated with certain illnesses, aiding in earlier and more precise diagnoses. As the focus on personalized medicine intensifies, carbohydrases offer a unique edge in developing diagnostics that cater to individual needs, solidifying their prominence in the future of diagnostic testing.
" By source, Microorganisms are estimated to dominate the market during the forecast period."
Microorganisms reign supreme in the source category of the specialty enzyme market due to their ideal qualities for various applications, particularly in research & biotechnology. Microbes like bacteria and fungi can be easily cultivated in controlled environments, allowing for scalable and cost-effective production of large enzyme quantities. This is crucial for research where consistent enzyme supplies are needed for experiments. The vast genetic diversity of microbes offers a treasure trove of enzymes with highly specific functions. Scientists can harness these enzymes to manipulate biomolecules with incredible precision, a necessity in research & biotechnology. For example, microbial enzymes can be used to selectively cut specific sections of DNA, facilitating gene editing techniques vital for creating new treatments and therapies. Furthermore, microbes can be genetically modified to create enzymes with novel properties, further expanding their potential in research endeavors. This unmatched versatility and adaptability solidify microorganism-derived enzymes as the leading source for the specialty enzyme market in research & biotechnology.
“Europe will significantly contribute towards market growth during the forecast period.”
Europe boasts a well-established healthcare infrastructure with strong government support for specialty enzyme industries. This translates to a high demand for innovative medical treatments, including those that utilize specialty enzymes. Europe's aging population creates a market for enzyme-based therapies for chronic diseases. Additionally, there's a growing focus on sustainable practices, and specialty enzymes offer a more eco-friendly alternative to traditional chemical catalysts in various industries. Furthermore, collaborations between European enzyme manufacturers and research institutions are accelerating market growth. For instance, According to CORDIS - EU research results, starting in December 2023, the EU-funded FuturEnzyme project aims to develop low-cost enzymes for eco-friendly consumers. Through innovative solutions and collaborative efforts, it will receive approximately USD 6.7 billion for enzyme discovery and optimization until May 2025.
Break-up of Primaries:
By Company Type: Tier1-40%, Tier 2-32%, Tier 3- 28%
By Designation: C-level-45%, D-level – 33%, and Others- 22%
By Region: North America - 15%, Europe - 20%, Asia Pacific – 40%, South America-12%, RoW – 13%,
Others include sales managers, territory managers, and product managers.
Leading players profiled in this report:
Research Coverage:
The report segments the specialty enzymes market based on type, source, form, applications, and region. In terms of insights, this report has focused on various levels of analyses—the competitive landscape, end-use analysis, and company profiles, which together comprise and discuss views on the emerging & high-growth segments of the global specialty enzymes market, high-growth regions, countries, government initiatives, drivers, restraints, opportunities, and challenges.
Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall specialty enzymes market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
" By source, Microorganisms are estimated to dominate the market during the forecast period."
Microorganisms reign supreme in the source category of the specialty enzyme market due to their ideal qualities for various applications, particularly in research & biotechnology. Microbes like bacteria and fungi can be easily cultivated in controlled environments, allowing for scalable and cost-effective production of large enzyme quantities. This is crucial for research where consistent enzyme supplies are needed for experiments. The vast genetic diversity of microbes offers a treasure trove of enzymes with highly specific functions. Scientists can harness these enzymes to manipulate biomolecules with incredible precision, a necessity in research & biotechnology. For example, microbial enzymes can be used to selectively cut specific sections of DNA, facilitating gene editing techniques vital for creating new treatments and therapies. Furthermore, microbes can be genetically modified to create enzymes with novel properties, further expanding their potential in research endeavors. This unmatched versatility and adaptability solidify microorganism-derived enzymes as the leading source for the specialty enzyme market in research & biotechnology.
“Europe will significantly contribute towards market growth during the forecast period.”
Europe boasts a well-established healthcare infrastructure with strong government support for specialty enzyme industries. This translates to a high demand for innovative medical treatments, including those that utilize specialty enzymes. Europe's aging population creates a market for enzyme-based therapies for chronic diseases. Additionally, there's a growing focus on sustainable practices, and specialty enzymes offer a more eco-friendly alternative to traditional chemical catalysts in various industries. Furthermore, collaborations between European enzyme manufacturers and research institutions are accelerating market growth. For instance, According to CORDIS - EU research results, starting in December 2023, the EU-funded FuturEnzyme project aims to develop low-cost enzymes for eco-friendly consumers. Through innovative solutions and collaborative efforts, it will receive approximately USD 6.7 billion for enzyme discovery and optimization until May 2025.
Break-up of Primaries:
By Company Type: Tier1-40%, Tier 2-32%, Tier 3- 28%
By Designation: C-level-45%, D-level – 33%, and Others- 22%
By Region: North America - 15%, Europe - 20%, Asia Pacific – 40%, South America-12%, RoW – 13%,
Others include sales managers, territory managers, and product managers.
Leading players profiled in this report:
- BRAIN Biotech AG (Germany)
- Novozymes A/S (Denmark)
- Codexis, Inc. (US)
- Sanofi (France)
- Merck KGaA (Germany)
- Dyadic International Inc (US)
- Advanced Enzyme Technologies (India)
- Amano Enzyme Inc (Japan)
- F. Hoffmann-La Roche Ltd (Switzerland)
- New England Biolabs (US)
- BBI Solutions (UK)
- Creative Enzymes (US)
- Bioseutica (Netherland)
- SEKISUI Diagnostics (US)
- Antozyme Biotech Pvt Ltd (India)
- S.I. Biozyme (India)
- Aumgene Biosciences (India)
- enzymebiosciences (India)
- Infinita Biotech Private Limited (India)
- Biolaxi Corporation (India)
- Fido Pharma Pvt. Ltd. (India)
- 4basebio (UK)
- Ansel Biotech (India)
- Geno Technology Inc. (US)
- Gujarat Enzyme (India)
Research Coverage:
The report segments the specialty enzymes market based on type, source, form, applications, and region. In terms of insights, this report has focused on various levels of analyses—the competitive landscape, end-use analysis, and company profiles, which together comprise and discuss views on the emerging & high-growth segments of the global specialty enzymes market, high-growth regions, countries, government initiatives, drivers, restraints, opportunities, and challenges.
Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall specialty enzymes market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
- Analysis of key drivers (Rise in Demand for Non-harmful Biological Catalysts in Pharmaceuticals & Diagnostics), restraints (Lack of Harmonization in the Regulatory Framework), opportunities (Lack of Harmonization in the Regulatory Framework), and challenges (Lack of Harmonization in the Regulatory Framework) influencing the growth of the specialty enzymes market.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the specialty enzymes market.
- Market Development: Comprehensive information about lucrative markets – the report analyses the specialty enzymes market across varied regions.
- Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the specialty enzymes market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as BRAIN Biotech AG (Germany), Novozymes A/S (Denmark), Codexis, Inc. (US), Sanofi (France), Merck KGaA (Germany), Dyadic International Inc (US), and Advanced Enzyme Technologies (India) among others in the specialty enzymes market strategies. The report also helps stakeholders understand the specialty enzymes market and provides them with information on key market drivers, restraints, challenges, and opportunities.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
FIGURE 1 MARKET SEGMENTATION
1.3.1 REGIONS COVERED
1.4 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
TABLE 1 USD EXCHANGE RATES, 2020–2023
1.6 UNIT CONSIDERED
1.7 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 2 SPECIALTY ENZYMES MARKET: RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.1.2.3 Breakdown of primary interviews
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY SPECIALTY ENZYME MANUFACTURER, DESIGNATION, AND REGION
2.2 FACTOR ANALYSIS
2.2.1 INTRODUCTION
2.2.2 DEMAND-SIDE ANALYSIS
FIGURE 4 KEY ECONOMIES BASED ON GDP, 2020–2023 (USD BILLION)
2.2.3 SUPPLY-SIDE ANALYSIS
FIGURE 5 R&D EXPENDITURE ON BIOTECHNOLOGY, BY COUNTRY, 2023 (USD BILLION)
2.3 MARKET SIZE ESTIMATION
2.3.1 APPROACH ONE (BASED ON APPLICATION, BY REGION)
2.3.2 APPROACH TWO (BASED ON GLOBAL MARKET)
2.4 DATA TRIANGULATION
FIGURE 6 DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH ASSUMPTIONS
2.6 LIMITATIONS & RISK ASSESSMENT
2.7 RECESSION IMPACT ANALYSIS
2.7.1 MACRO-INDICATORS OF RECESSION
FIGURE 7 RECESSION INDICATORS
FIGURE 8 GLOBAL INFLATION RATE, 2013–2023
FIGURE 9 GLOBAL GROSS DOMESTIC PRODUCT, 2013–2023 (USD TRILLION)
FIGURE 10 RECESSION INDICATORS AND THEIR IMPACT ON SPECIALTY ENZYMES MARKET
FIGURE 11 SPECIALTY ENZYMES MARKET: CURRENT FORECAST VS. RECESSION FORECAST
3 EXECUTIVE SUMMARY
TABLE 2 SPECIALTY ENZYMES MARKET SNAPSHOT, 2024 VS. 2029
FIGURE 12 SPECIALTY ENZYMES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 13 SPECIALTY ENZYMES MARKET, BY SOURCE, 2024 VS. 2029 (USD MILLION)
FIGURE 14 SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 15 SPECIALTY ENZYMES MARKET: REGIONAL SNAPSHOT
4 PREMIUM INSIGHTS
4.1 OPPORTUNITIES FOR PLAYERS IN SPECIALTY ENZYMES MARKET
FIGURE 16 ADVANCEMENTS IN DRUG DEVELOPMENT AND DISEASE DIAGNOSIS TO DRIVE DEMAND FOR SPECIALTY ENZYMES
4.2 SPECIALTY ENZYMES MARKET: SHARE OF MAJOR REGIONAL SUBMARKETS
FIGURE 17 US ACCOUNTED FOR LARGEST SHARE IN 2023
4.3 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY SOURCE & KEY COUNTRY
FIGURE 18 MICROORGANISMS SEGMENT AND CHINA TO ACCOUNT FOR SIGNIFICANT SHARE IN 2024
4.4 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE
FIGURE 19 CARBOHYDRASES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
4.5 EUROPE: SPECIALTY ENZYMES MARKET, BY APPLICATION
FIGURE 20 PHARMACEUTICALS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MACROECONOMIC INDICATORS
5.2.1 INCREASE IN RETAIL SALES
FIGURE 21 RETAIL AND FOOD SERVICE SALES IN US, 2018–2023 (USD BILLION)
5.2.2 GROWTH OPPORTUNITIES FOR MARKET IN ASIA PACIFIC AND SOUTH AMERICA
FIGURE 22 ANNUAL GDP GROWTH RATE IN ASIAN COUNTRIES, 2022
5.3 MARKET DYNAMICS
FIGURE 23 SPECIALTY ENZYMES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.3.1 DRIVERS
5.3.1.1 Rise in demand for non-harmful biological catalysts in pharmaceuticals and diagnostics
5.3.1.2 Supportive government policies and funding
5.3.1.3 Advanced tools to optimize pharmaceutical production
FIGURE 24 EUROPE: PRODUCTION VALUE OF PHARMACEUTICALS, 2000–2022 (USD MILLION)
5.3.2 RESTRAINTS
5.3.2.1 Lack of harmonization in regulatory framework
5.3.2.2 High costs associated with specialty enzymes
5.3.3 OPPORTUNITIES
5.3.3.1 Rising significance of catalysts in pharmaceutical industry
5.3.3.2 Technological innovations and wide industry scope
FIGURE 25 GROSS DOMESTIC EXPENDITURE ON R&D, 2017–2023 (USD BILLION)
5.3.3.3 Development of enzymes with long shelf life
5.3.3.4 Need for encapsulation to enhance shelf life of enzymes
5.3.3.5 Utilization of plant biomass for production of specialty enzymes
5.3.4 CHALLENGES
5.3.4.1 High research and development costs
5.3.4.2 Competition from alternative technologies or products
6 INDUSTRY TRENDS
6.1 INTRODUCTION
6.2 SUPPLY CHAIN ANALYSIS
FIGURE 26 SUPPLY CHAIN ANALYSIS
6.3 VALUE CHAIN ANALYSIS
FIGURE 27 SPECIALTY ENZYMES MARKET: VALUE CHAIN ANALYSIS
6.4 TRADE ANALYSIS
6.4.1 EXPORT SCENARIO OF SPECIALTY ENZYMES
FIGURE 28 EXPORT VALUE OF SPECIALTY ENZYMES FOR KEY COUNTRIES, 2020–2023 (USD THOUSAND)
TABLE 3 TOP FIVE EXPORTERS OF SPECIALTY ENZYMES (HS CODE 350790), 2023 (USD THOUSAND)
6.4.2 IMPORT SCENARIO OF SPECIALTY ENZYMES
FIGURE 29 IMPORT VALUE OF SPECIALTY ENZYMES FOR KEY COUNTRIES, 2020–2023 (USD THOUSAND)
TABLE 4 TOP FIVE IMPORTERS OF SPECIALTY ENZYMES (HS CODE 350790), 2023 (USD THOUSAND)
6.5 TECHNOLOGY ANALYSIS
6.5.1 KEY TECHNOLOGIES
6.5.1.1 Protein engineering for drug delivery
6.5.1.2 Next-Generation Sequencing (NGS) for enzyme-based diagnostics
6.5.1.3 Directed evolution of enzymes
6.5.2 ADJACENT TECHNOLOGIES
6.5.2.1 Food enzymes immobilization
6.6 PRICING ANALYSIS
6.6.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY APPLICATION
FIGURE 30 AVERAGE SELLING PRICE TREND OF KEY PLAYERS FOR KEY APPLICATIONS, 2022–2023 (USD/KG)
TABLE 5 AVERAGE SELLING PRICE OF KEY PLAYERS FOR KEY APPLICATIONS, 2020–2023 (USD/KG)
6.6.2 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION
FIGURE 31 SPECIALTY ENZYMES MARKET: AVERAGE SELLING PRICE TREND, BY REGION, 2020–2023 (USD/KG)
TABLE 6 SPECIALTY ENZYMES MARKET: AVERAGE SELLING PRICE TREND, BY REGION, 2020–2023 (USD/KG)
6.7 ECOSYSTEM
6.7.1 SUPPLY SIDE
6.7.2 DEMAND SIDE
FIGURE 32 SPECIALTY ENZYMES MARKET ECOSYSTEM
TABLE 7 SPECIALTY ENZYMES MARKET: ECOSYSTEM
6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 33 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
6.9 PATENT ANALYSIS
FIGURE 34 LIST OF MAJOR PATENTS IN SPECIALTY ENZYMES MARKET
TABLE 8 LIST OF MAJOR PATENTS PUBLISHED, 2020–2024
6.10 KEY CONFERENCES & EVENTS, 2024–2025
TABLE 9 SPECIALTY ENZYMES MARKET: LIST OF KEY CONFERENCES & EVENTS, 2024–2025
6.11 REGULATORY LANDSCAPE
6.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
6.11.2 REGULATIONS, BY REGION
6.11.2.1 North America
6.11.2.1.1 US
6.11.2.1.2 Canada
6.11.2.2 Europe
6.11.2.2.1 European Union
6.11.2.3 Asia Pacific
6.11.2.3.1 China
6.11.2.3.2 India
6.11.2.4 South America
6.11.2.4.1 Brazil
6.12 PORTER’S FIVE FORCES ANALYSIS
TABLE 14 SPECIALTY ENZYMES MARKET: PORTER’S FIVE FORCES ANALYSIS
6.12.1 INTENSITY OF COMPETITIVE RIVALRY
6.12.2 BARGAINING POWER OF SUPPLIERS
6.12.3 BARGAINING POWER OF BUYERS
6.12.4 THREAT OF SUBSTITUTES
6.12.5 THREAT OF NEW ENTRANTS
6.13 KEY STAKEHOLDERS & BUYING CRITERIA
6.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 35 INFLUENCE OF STAKEHOLDERS ON PURCHASE OF SPECIALTY ENZYMES FROM VARIOUS SOURCES
TABLE 15 INFLUENCE OF STAKEHOLDERS ON PURCHASE OF ENZYMES FROM VARIOUS SOURCES
6.13.2 BUYING CRITERIA
TABLE 16 KEY BUYING CRITERIA FOR TOP FOUR SPECIALTY ENZYME APPLICATIONS
FIGURE 36 KEY BUYING CRITERIA FOR TOP THREE SPECIALTY ENZYME APPLICATIONS
6.14 CASE STUDIES
6.14.1 BIOCATALYSTS ASSEMBLED MULTI-SKILLED PROJECT TEAM AND PRIORITIZED ON-SITE PRESENCE TO OVERCOME REMOTE WORKING CHALLENGES DURING COMMISSIONING PROCESS
6.14.2 CODEXIS DEPLOYED ITS CODEEVOLVER PLATFORM TO DEVELOP HIGHLY EFFICIENT AND STEREOSPECIFIC KETOREDUCTASE ENZYMES
6.14.3 THERMO FISHER SCIENTIFIC UTILIZED DIRECTED EVOLUTION TECHNIQUES TO ENGINEER NOVEL VARIANT OF PHI29 DNA POLYMERASE
6.15 INVESTMENT AND FUNDING SCENARIO
FIGURE 37 INVESTMENT AND FUNDING SCENARIO
7 SPECIALTY ENZYMES MARKET, BY TYPE
7.1 INTRODUCTION
FIGURE 38 SPECIALTY ENZYMES MARKET, BY TYPE, 2024 VS. 2029
TABLE 17 SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 18 SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 19 SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (KILOTONS)
TABLE 20 SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (KILOTONS)
7.2 CARBOHYDRASES
7.2.1 APPLICATIONS OF CARBOHYDRASES IN PHARMACEUTICAL, RESEARCH, AND BIOTECHNOLOGY SECTORS TO FUEL MARKET GROWTH
TABLE 21 CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
TABLE 22 CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 23 CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY SUBTYPE, 2020–2023 (USD MILLION)
TABLE 24 CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY SUBTYPE, 2024–2029 (USD MILLION)
TABLE 25 CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 26 CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
7.2.2 AMYLASES
TABLE 27 AMYLASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 28 AMYLASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
7.2.3 CELLULASES
TABLE 29 CELLULASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 30 CELLULASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
7.2.4 OTHER CARBOHYDRASES
TABLE 31 OTHER CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 32 OTHER CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
7.3 PROTEASES
7.3.1 INNOVATIVE PRODUCTS TAILORED FOR SPECIFIC APPLICATIONS TO DRIVE MARKET
TABLE 33 PROTEASES: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
TABLE 34 PROTEASES: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 35 PROTEASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 36 PROTEASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
7.4 LIPASES
7.4.1 USAGE OF LIPASES IN VARIOUS INDUSTRIAL AND SPECIALTY APPLICATIONS TO DRIVE MARKET
TABLE 37 LIPASES: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
TABLE 38 LIPASES: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 39 LIPASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 40 LIPASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
7.5 POLYMERASES & NUCLEASES
7.5.1 PIVOTAL ROLE OF POLYMERASES AND NUCLEASES IN ADVANCING NEXT-GENERATION SEQUENCING TECHNOLOGIES TO ACCELERATE MARKET GROWTH
TABLE 41 POLYMERASES & NUCLEASES: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
TABLE 42 POLYMERASES & NUCLEASES: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 43 POLYMERASES & NUCLEASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 44 POLYMERASES & NUCLEASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
7.6 OTHER ENZYMES
TABLE 45 USAGE OF OTHER ENZYMES IN VARIOUS APPLICATIONS
TABLE 46 OTHER ENZYMES: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
TABLE 47 OTHER ENZYMES: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 48 OTHER ENZYMES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 49 OTHER ENZYMES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
8 SPECIALTY ENZYMES MARKET, BY FORM
8.1 INTRODUCTION
8.2 LIQUID
8.2.1 NEED FOR REPLACING CHEMICAL CATALYSTS IN DIAGNOSIS OF VARIOUS CHRONIC DISEASES TO BOOST DEMAND FOR LIQUID ENZYMES
8.3 DRY
8.3.1 ENHANCED STABILITY DURING STORAGE AND TRANSPORTATION, SIMPLIFIED ASSAY PROCEDURES, AND REDUCED RISK OF CONTAMINATION TO PROPEL MARKET GROWTH
FIGURE 39 FLOWCHART REPRESENTING PRODUCTION OF DRY ENZYMES
9 SPECIALTY ENZYMES MARKET, BY SOURCE
9.1 INTRODUCTION
FIGURE 40 SPECIALTY ENZYMES MARKET, BY SOURCE, 2024 VS. 2029
TABLE 50 SPECIALTY ENZYMES MARKET, BY SOURCE, 2020–2023 (USD MILLION)
TABLE 51 SPECIALTY ENZYMES MARKET, BY SOURCE, 2024–2029 (USD MILLION)
9.2 MICROORGANISMS
9.2.1 NEED FOR ECONOMIC FEASIBILITY, HIGH YIELDS, CONSISTENCY, AND EASE OF PRODUCT OPTIMIZATION OF SPECIALTY ENZYMES TO BOOST MARKET
TABLE 52 MICROORGANISMS: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
TABLE 53 MICROORGANISMS: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
9.3 PLANTS
9.3.1 ENZYMES DERIVED FROM PLANTS SPEED UP BIOCHEMICAL REACTIONS AND FUNCTION IN ACIDIC ENVIRONMENT
TABLE 54 PLANTS: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
TABLE 55 PLANTS: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
9.4 ANIMALS
9.4.1 ANIMAL-DERIVED ENZYMES FOCUS ON ENHANCING DRUG FORMULATION AND SYNTHESIS PROCESSES
TABLE 56 ANIMALS: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
TABLE 57 ANIMALS: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
10 SPECIALTY ENZYMES MARKET, BY APPLICATION
10.1 INTRODUCTION
FIGURE 41 SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024 VS. 2029
TABLE 58 SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 59 SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
10.2 PHARMACEUTICALS
10.2.1 INCREASING INCORPORATION OF ENZYMES IN THERAPIES TO DRIVE MARKET
TABLE 60 PHARMACEUTICALS: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
TABLE 61 PHARMACEUTICALS: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 62 PHARMACEUTICALS: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 63 PHARMACEUTICALS: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
10.3 RESEARCH & BIOTECHNOLOGY
10.3.1 DROP IN DNA SEQUENCING COSTS AND RISE IN NEW SEQUENCING TECHNIQUES TO BOOST MARKET
TABLE 64 RESEARCH & BIOTECHNOLOGY: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
TABLE 65 RESEARCH & BIOTECHNOLOGY: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 66 RESEARCH & BIOTECHNOLOGY: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 67 RESEARCH & BIOTECHNOLOGY: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
10.4 DIAGNOSTICS
10.4.1 SURGE IN INVESTMENTS AND RISING GERIATRIC POPULATION TO ACCELERATE MARKET GROWTH
TABLE 68 DIAGNOSTICS: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
TABLE 69 DIAGNOSTICS: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 70 DIAGNOSTICS: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 71 DIAGNOSTICS: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
10.5 BIOCATALYSTS
10.5.1 BIODEGRADATION OF PLASTICS BY MICROORGANISMS TO DRIVE DEMAND FOR ENZYMES
TABLE 72 BIOCATALYSTS: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
TABLE 73 BIOCATALYSTS: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 74 BIOCATALYSTS: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 75 BIOCATALYSTS: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11 SPECIALTY ENZYMES MARKET, BY REGION
11.1 INTRODUCTION
FIGURE 42 ASIA PACIFIC TO RECORD HIGHEST GROWTH DURING FORECAST PERIOD
TABLE 76 SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
TABLE 77 SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 78 SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (KILOTONS)
TABLE 79 SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (KILOTONS)
11.2 NORTH AMERICA
FIGURE 43 NORTH AMERICAN SPECIALTY ENZYMES MARKET SNAPSHOT
11.2.1 NORTH AMERICA: RECESSION IMPACT ANALYSIS
FIGURE 44 NORTH AMERICA: INFLATION RATES, BY KEY COUNTRY, 2017–2022
FIGURE 45 NORTH AMERICA: RECESSION IMPACT ANALYSIS, 2023
TABLE 80 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
TABLE 81 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 82 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 83 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 84 NORTH AMERICA: CARBOHYDRASES MARKET, BY SUBTYPE, 2020–2023 (USD MILLION)
TABLE 85 NORTH AMERICA: CARBOHYDRASES MARKET, BY SUBTYPE, 2024–2029 (USD MILLION)
TABLE 86 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY SOURCE, 2020–2023 (USD MILLION)
TABLE 87 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY SOURCE, 2024–2029 (USD MILLION)
TABLE 88 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 89 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
11.2.2 US
11.2.2.1 Increasing awareness among manufacturers regarding usage of enzymes for enhanced product quality to drive market
TABLE 90 US: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 91 US: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 92 US: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 93 US: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.2.3 CANADA
11.2.3.1 Rise in cancer cases to lead to increased use of specialty enzymes in diagnostics
TABLE 94 CANADA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 95 CANADA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 96 CANADA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 97 CANADA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.2.4 MEXICO
11.2.4.1 Need for detecting changes in substrate concentrations to boost market growth
TABLE 98 MEXICO: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 99 MEXICO: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 100 MEXICO: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 101 MEXICO: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.3 EUROPE
11.3.1 EUROPE: RECESSION IMPACT ANALYSIS
FIGURE 46 EUROPE: INFLATION RATES, BY KEY COUNTRY, 2017–2022
FIGURE 47 EUROPE: RECESSION IMPACT ANALYSIS, 2023
TABLE 102 EUROPE: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
TABLE 103 EUROPE: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 104 EUROPE: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 105 EUROPE: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 106 EUROPE: CARBOHYDRASES MARKET, BY SUBTYPE, 2020–2023 (USD MILLION)
TABLE 107 EUROPE: CARBOHYDRASES MARKET, BY SUBTYPE, 2024–2029 (USD MILLION)
TABLE 108 EUROPE: SPECIALTY ENZYMES MARKET, BY SOURCE, 2020–2023 (USD MILLION)
TABLE 109 EUROPE: SPECIALTY ENZYMES MARKET, BY SOURCE, 2024–2029 (USD MILLION)
TABLE 110 EUROPE: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 111 EUROPE: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
11.3.2 ITALY
11.3.2.1 Rise in production of pharmaceuticals to drive demand for specialty enzymes
TABLE 112 ITALY: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 113 ITALY: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 114 ITALY: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 115 ITALY: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.3.3 GERMANY
11.3.3.1 Rapid technological advancements in pharmaceuticals sector to boost growth
TABLE 116 GERMANY: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 117 GERMANY: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 118 GERMANY: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 119 GERMANY: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.3.4 FRANCE
11.3.4.1 Clinical developments impacting French biotechnology industry to increase usage of specialty enzymes
TABLE 120 FRANCE: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 121 FRANCE: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 122 FRANCE: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 123 FRANCE: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.3.5 SPAIN
11.3.5.1 Spanish government’s emphasis on developments in pharmaceutical industry to boost enzymes market
TABLE 124 SPAIN: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 125 SPAIN: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 126 SPAIN: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 127 SPAIN: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.3.6 UK
11.3.6.1 Increased use of enzymes in drug cloning technique to spur demand
TABLE 128 UK: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 129 UK: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 130 UK: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 131 UK: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.3.7 DENMARK
11.3.7.1 Growing export of enzymes to propel demand for specialty enzymes
TABLE 132 DENMARK: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 133 DENMARK: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 134 DENMARK: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 135 DENMARK: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.3.8 NETHERLANDS
11.3.8.1 Sustainable lifestyle and demand for environment-friendly products to boost popularity of specialty enzymes
TABLE 136 NETHERLANDS: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 137 NETHERLANDS: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 138 NETHERLANDS: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 139 NETHERLANDS: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.3.9 REST OF EUROPE
TABLE 140 REST OF EUROPE: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 141 REST OF EUROPE: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 142 REST OF EUROPE: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 143 REST OF EUROPE: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.4 ASIA PACIFIC
FIGURE 48 ASIA PACIFIC SPECIALTY ENZYMES MARKET SNAPSHOT
11.4.1 ASIA PACIFIC: RECESSION IMPACT ANALYSIS
FIGURE 49 ASIA PACIFIC: INFLATION RATES, BY KEY COUNTRY, 2017–2022
FIGURE 50 ASIA PACIFIC: RECESSION IMPACT ANALYSIS, 2023
TABLE 144 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
TABLE 145 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 146 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 147 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 148 ASIA PACIFIC: CARBOHYDRASES MARKET, BY SUBTYPE, 2020–2023 (USD MILLION)
TABLE 149 ASIA PACIFIC: CARBOHYDRASES MARKET, BY SUBTYPE, 2024–2029 (USD MILLION)
TABLE 150 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY SOURCE, 2020–2023 (USD MILLION)
TABLE 151 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY SOURCE, 2024–2029 (USD MILLION)
TABLE 152 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 153 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
11.4.2 CHINA
11.4.2.1 Rapid technical advancements to augment demand for specialty enzymes
TABLE 154 CHINA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 155 CHINA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 156 CHINA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 157 CHINA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.4.3 INDIA
11.4.3.1 Rising demand for specialty enzymes in pharmaceutical industry to boost market
TABLE 158 INDIA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 159 INDIA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 160 INDIA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 161 INDIA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.4.4 JAPAN
11.4.4.1 Growing biotechnology advancements in Japan to augment demand for specialty enzymes
TABLE 162 JAPAN: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 163 JAPAN: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 164 JAPAN: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 165 JAPAN: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.4.5 SOUTH KOREA
11.4.5.1 Advancements in biotechnology, medical research, and biopharmaceuticals to boost usage of specialty enzymes
TABLE 166 SOUTH KOREA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 167 SOUTH KOREA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 168 SOUTH KOREA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 169 SOUTH KOREA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.4.6 AUSTRALIA & NEW ZEALAND
11.4.6.1 Favorable government regulations to increase biotechnology advancements and rise in popularity of specialty enzymes
TABLE 170 AUSTRALIA & NEW ZEALAND: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 171 AUSTRALIA & NEW ZEALAND: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 172 AUSTRALIA & NEW ZEALAND: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 173 AUSTRALIA & NEW ZEALAND: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.4.7 REST OF ASIA PACIFIC
TABLE 174 REST OF ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 175 REST OF ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 176 REST OF ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 177 REST OF ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.5 SOUTH AMERICA
11.5.1 SOUTH AMERICA: RECESSION IMPACT
FIGURE 51 SOUTH AMERICA: INFLATION RATES, BY KEY COUNTRY, 2018–2022
FIGURE 52 SOUTH AMERICA: RECESSION IMPACT ANALYSIS, 2023
TABLE 178 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
TABLE 179 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 180 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 181 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 182 SOUTH AMERICA: CARBOHYDRASES MARKET, BY SUBTYPE, 2020–2023 (USD MILLION)
TABLE 183 SOUTH AMERICA: CARBOHYDRASES MARKET, BY SUBTYPE, 2024–2029 (USD MILLION)
TABLE 184 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY SOURCE, 2020–2023 (USD MILLION)
TABLE 185 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY SOURCE, 2024–2029 (USD MILLION)
TABLE 186 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 187 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
11.5.2 BRAZIL
11.5.2.1 Thriving pharmaceutical industry to drive demand for enzymes
TABLE 188 BRAZIL: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 189 BRAZIL: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 190 BRAZIL: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 191 BRAZIL: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.5.3 ARGENTINA
11.5.3.1 Government support in pharmaceuticals and research and development to boost growth
TABLE 192 ARGENTINA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 193 ARGENTINA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 194 ARGENTINA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 195 ARGENTINA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.5.4 REST OF SOUTH AMERICA
TABLE 196 REST OF SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 197 REST OF SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 198 REST OF SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 199 REST OF SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.6 REST OF THE WORLD
11.6.1 REST OF THE WORLD: RECESSION IMPACT ANALYSIS
FIGURE 53 REST OF THE WORLD: INFLATION RATES, BY KEY COUNTRY, 2017–2022
FIGURE 54 REST OF THE WORLD: RECESSION IMPACT ANALYSIS, 2023
TABLE 200 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
TABLE 201 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 202 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 203 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 204 REST OF THE WORLD: CARBOHYDRASES MARKET, BY SUBTYPE, 2020–2023 (USD MILLION)
TABLE 205 REST OF THE WORLD: CARBOHYDRASES MARKET, BY SUBTYPE, 2024–2029 (USD MILLION)
TABLE 206 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY SOURCE, 2020–2023 (USD MILLION)
TABLE 207 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY SOURCE, 2024–2029 (USD MILLION)
TABLE 208 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 209 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
11.6.2 AFRICA
11.6.2.1 Rising demand for generic medicines to boost adoption of specialty enzymes in pharmaceutical industry
TABLE 210 AFRICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 211 AFRICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 212 AFRICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 213 AFRICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.6.3 MIDDLE EAST
11.6.3.1 Government initiatives to promote biotechnological research and development to drive demand
TABLE 214 MIDDLE EAST: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 215 MIDDLE EAST: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 216 MIDDLE EAST: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 217 MIDDLE EAST: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
FIGURE 1 MARKET SEGMENTATION
1.3.1 REGIONS COVERED
1.4 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
TABLE 1 USD EXCHANGE RATES, 2020–2023
1.6 UNIT CONSIDERED
1.7 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 2 SPECIALTY ENZYMES MARKET: RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.1.2.3 Breakdown of primary interviews
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY SPECIALTY ENZYME MANUFACTURER, DESIGNATION, AND REGION
2.2 FACTOR ANALYSIS
2.2.1 INTRODUCTION
2.2.2 DEMAND-SIDE ANALYSIS
FIGURE 4 KEY ECONOMIES BASED ON GDP, 2020–2023 (USD BILLION)
2.2.3 SUPPLY-SIDE ANALYSIS
FIGURE 5 R&D EXPENDITURE ON BIOTECHNOLOGY, BY COUNTRY, 2023 (USD BILLION)
2.3 MARKET SIZE ESTIMATION
2.3.1 APPROACH ONE (BASED ON APPLICATION, BY REGION)
2.3.2 APPROACH TWO (BASED ON GLOBAL MARKET)
2.4 DATA TRIANGULATION
FIGURE 6 DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH ASSUMPTIONS
2.6 LIMITATIONS & RISK ASSESSMENT
2.7 RECESSION IMPACT ANALYSIS
2.7.1 MACRO-INDICATORS OF RECESSION
FIGURE 7 RECESSION INDICATORS
FIGURE 8 GLOBAL INFLATION RATE, 2013–2023
FIGURE 9 GLOBAL GROSS DOMESTIC PRODUCT, 2013–2023 (USD TRILLION)
FIGURE 10 RECESSION INDICATORS AND THEIR IMPACT ON SPECIALTY ENZYMES MARKET
FIGURE 11 SPECIALTY ENZYMES MARKET: CURRENT FORECAST VS. RECESSION FORECAST
3 EXECUTIVE SUMMARY
TABLE 2 SPECIALTY ENZYMES MARKET SNAPSHOT, 2024 VS. 2029
FIGURE 12 SPECIALTY ENZYMES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 13 SPECIALTY ENZYMES MARKET, BY SOURCE, 2024 VS. 2029 (USD MILLION)
FIGURE 14 SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 15 SPECIALTY ENZYMES MARKET: REGIONAL SNAPSHOT
4 PREMIUM INSIGHTS
4.1 OPPORTUNITIES FOR PLAYERS IN SPECIALTY ENZYMES MARKET
FIGURE 16 ADVANCEMENTS IN DRUG DEVELOPMENT AND DISEASE DIAGNOSIS TO DRIVE DEMAND FOR SPECIALTY ENZYMES
4.2 SPECIALTY ENZYMES MARKET: SHARE OF MAJOR REGIONAL SUBMARKETS
FIGURE 17 US ACCOUNTED FOR LARGEST SHARE IN 2023
4.3 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY SOURCE & KEY COUNTRY
FIGURE 18 MICROORGANISMS SEGMENT AND CHINA TO ACCOUNT FOR SIGNIFICANT SHARE IN 2024
4.4 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE
FIGURE 19 CARBOHYDRASES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
4.5 EUROPE: SPECIALTY ENZYMES MARKET, BY APPLICATION
FIGURE 20 PHARMACEUTICALS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MACROECONOMIC INDICATORS
5.2.1 INCREASE IN RETAIL SALES
FIGURE 21 RETAIL AND FOOD SERVICE SALES IN US, 2018–2023 (USD BILLION)
5.2.2 GROWTH OPPORTUNITIES FOR MARKET IN ASIA PACIFIC AND SOUTH AMERICA
FIGURE 22 ANNUAL GDP GROWTH RATE IN ASIAN COUNTRIES, 2022
5.3 MARKET DYNAMICS
FIGURE 23 SPECIALTY ENZYMES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.3.1 DRIVERS
5.3.1.1 Rise in demand for non-harmful biological catalysts in pharmaceuticals and diagnostics
5.3.1.2 Supportive government policies and funding
5.3.1.3 Advanced tools to optimize pharmaceutical production
FIGURE 24 EUROPE: PRODUCTION VALUE OF PHARMACEUTICALS, 2000–2022 (USD MILLION)
5.3.2 RESTRAINTS
5.3.2.1 Lack of harmonization in regulatory framework
5.3.2.2 High costs associated with specialty enzymes
5.3.3 OPPORTUNITIES
5.3.3.1 Rising significance of catalysts in pharmaceutical industry
5.3.3.2 Technological innovations and wide industry scope
FIGURE 25 GROSS DOMESTIC EXPENDITURE ON R&D, 2017–2023 (USD BILLION)
5.3.3.3 Development of enzymes with long shelf life
5.3.3.4 Need for encapsulation to enhance shelf life of enzymes
5.3.3.5 Utilization of plant biomass for production of specialty enzymes
5.3.4 CHALLENGES
5.3.4.1 High research and development costs
5.3.4.2 Competition from alternative technologies or products
6 INDUSTRY TRENDS
6.1 INTRODUCTION
6.2 SUPPLY CHAIN ANALYSIS
FIGURE 26 SUPPLY CHAIN ANALYSIS
6.3 VALUE CHAIN ANALYSIS
FIGURE 27 SPECIALTY ENZYMES MARKET: VALUE CHAIN ANALYSIS
6.4 TRADE ANALYSIS
6.4.1 EXPORT SCENARIO OF SPECIALTY ENZYMES
FIGURE 28 EXPORT VALUE OF SPECIALTY ENZYMES FOR KEY COUNTRIES, 2020–2023 (USD THOUSAND)
TABLE 3 TOP FIVE EXPORTERS OF SPECIALTY ENZYMES (HS CODE 350790), 2023 (USD THOUSAND)
6.4.2 IMPORT SCENARIO OF SPECIALTY ENZYMES
FIGURE 29 IMPORT VALUE OF SPECIALTY ENZYMES FOR KEY COUNTRIES, 2020–2023 (USD THOUSAND)
TABLE 4 TOP FIVE IMPORTERS OF SPECIALTY ENZYMES (HS CODE 350790), 2023 (USD THOUSAND)
6.5 TECHNOLOGY ANALYSIS
6.5.1 KEY TECHNOLOGIES
6.5.1.1 Protein engineering for drug delivery
6.5.1.2 Next-Generation Sequencing (NGS) for enzyme-based diagnostics
6.5.1.3 Directed evolution of enzymes
6.5.2 ADJACENT TECHNOLOGIES
6.5.2.1 Food enzymes immobilization
6.6 PRICING ANALYSIS
6.6.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY APPLICATION
FIGURE 30 AVERAGE SELLING PRICE TREND OF KEY PLAYERS FOR KEY APPLICATIONS, 2022–2023 (USD/KG)
TABLE 5 AVERAGE SELLING PRICE OF KEY PLAYERS FOR KEY APPLICATIONS, 2020–2023 (USD/KG)
6.6.2 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION
FIGURE 31 SPECIALTY ENZYMES MARKET: AVERAGE SELLING PRICE TREND, BY REGION, 2020–2023 (USD/KG)
TABLE 6 SPECIALTY ENZYMES MARKET: AVERAGE SELLING PRICE TREND, BY REGION, 2020–2023 (USD/KG)
6.7 ECOSYSTEM
6.7.1 SUPPLY SIDE
6.7.2 DEMAND SIDE
FIGURE 32 SPECIALTY ENZYMES MARKET ECOSYSTEM
TABLE 7 SPECIALTY ENZYMES MARKET: ECOSYSTEM
6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 33 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
6.9 PATENT ANALYSIS
FIGURE 34 LIST OF MAJOR PATENTS IN SPECIALTY ENZYMES MARKET
TABLE 8 LIST OF MAJOR PATENTS PUBLISHED, 2020–2024
6.10 KEY CONFERENCES & EVENTS, 2024–2025
TABLE 9 SPECIALTY ENZYMES MARKET: LIST OF KEY CONFERENCES & EVENTS, 2024–2025
6.11 REGULATORY LANDSCAPE
6.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
6.11.2 REGULATIONS, BY REGION
6.11.2.1 North America
6.11.2.1.1 US
6.11.2.1.2 Canada
6.11.2.2 Europe
6.11.2.2.1 European Union
6.11.2.3 Asia Pacific
6.11.2.3.1 China
6.11.2.3.2 India
6.11.2.4 South America
6.11.2.4.1 Brazil
6.12 PORTER’S FIVE FORCES ANALYSIS
TABLE 14 SPECIALTY ENZYMES MARKET: PORTER’S FIVE FORCES ANALYSIS
6.12.1 INTENSITY OF COMPETITIVE RIVALRY
6.12.2 BARGAINING POWER OF SUPPLIERS
6.12.3 BARGAINING POWER OF BUYERS
6.12.4 THREAT OF SUBSTITUTES
6.12.5 THREAT OF NEW ENTRANTS
6.13 KEY STAKEHOLDERS & BUYING CRITERIA
6.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 35 INFLUENCE OF STAKEHOLDERS ON PURCHASE OF SPECIALTY ENZYMES FROM VARIOUS SOURCES
TABLE 15 INFLUENCE OF STAKEHOLDERS ON PURCHASE OF ENZYMES FROM VARIOUS SOURCES
6.13.2 BUYING CRITERIA
TABLE 16 KEY BUYING CRITERIA FOR TOP FOUR SPECIALTY ENZYME APPLICATIONS
FIGURE 36 KEY BUYING CRITERIA FOR TOP THREE SPECIALTY ENZYME APPLICATIONS
6.14 CASE STUDIES
6.14.1 BIOCATALYSTS ASSEMBLED MULTI-SKILLED PROJECT TEAM AND PRIORITIZED ON-SITE PRESENCE TO OVERCOME REMOTE WORKING CHALLENGES DURING COMMISSIONING PROCESS
6.14.2 CODEXIS DEPLOYED ITS CODEEVOLVER PLATFORM TO DEVELOP HIGHLY EFFICIENT AND STEREOSPECIFIC KETOREDUCTASE ENZYMES
6.14.3 THERMO FISHER SCIENTIFIC UTILIZED DIRECTED EVOLUTION TECHNIQUES TO ENGINEER NOVEL VARIANT OF PHI29 DNA POLYMERASE
6.15 INVESTMENT AND FUNDING SCENARIO
FIGURE 37 INVESTMENT AND FUNDING SCENARIO
7 SPECIALTY ENZYMES MARKET, BY TYPE
7.1 INTRODUCTION
FIGURE 38 SPECIALTY ENZYMES MARKET, BY TYPE, 2024 VS. 2029
TABLE 17 SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 18 SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 19 SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (KILOTONS)
TABLE 20 SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (KILOTONS)
7.2 CARBOHYDRASES
7.2.1 APPLICATIONS OF CARBOHYDRASES IN PHARMACEUTICAL, RESEARCH, AND BIOTECHNOLOGY SECTORS TO FUEL MARKET GROWTH
TABLE 21 CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
TABLE 22 CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 23 CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY SUBTYPE, 2020–2023 (USD MILLION)
TABLE 24 CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY SUBTYPE, 2024–2029 (USD MILLION)
TABLE 25 CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 26 CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
7.2.2 AMYLASES
TABLE 27 AMYLASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 28 AMYLASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
7.2.3 CELLULASES
TABLE 29 CELLULASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 30 CELLULASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
7.2.4 OTHER CARBOHYDRASES
TABLE 31 OTHER CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 32 OTHER CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
7.3 PROTEASES
7.3.1 INNOVATIVE PRODUCTS TAILORED FOR SPECIFIC APPLICATIONS TO DRIVE MARKET
TABLE 33 PROTEASES: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
TABLE 34 PROTEASES: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 35 PROTEASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 36 PROTEASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
7.4 LIPASES
7.4.1 USAGE OF LIPASES IN VARIOUS INDUSTRIAL AND SPECIALTY APPLICATIONS TO DRIVE MARKET
TABLE 37 LIPASES: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
TABLE 38 LIPASES: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 39 LIPASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 40 LIPASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
7.5 POLYMERASES & NUCLEASES
7.5.1 PIVOTAL ROLE OF POLYMERASES AND NUCLEASES IN ADVANCING NEXT-GENERATION SEQUENCING TECHNOLOGIES TO ACCELERATE MARKET GROWTH
TABLE 41 POLYMERASES & NUCLEASES: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
TABLE 42 POLYMERASES & NUCLEASES: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 43 POLYMERASES & NUCLEASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 44 POLYMERASES & NUCLEASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
7.6 OTHER ENZYMES
TABLE 45 USAGE OF OTHER ENZYMES IN VARIOUS APPLICATIONS
TABLE 46 OTHER ENZYMES: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
TABLE 47 OTHER ENZYMES: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 48 OTHER ENZYMES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 49 OTHER ENZYMES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
8 SPECIALTY ENZYMES MARKET, BY FORM
8.1 INTRODUCTION
8.2 LIQUID
8.2.1 NEED FOR REPLACING CHEMICAL CATALYSTS IN DIAGNOSIS OF VARIOUS CHRONIC DISEASES TO BOOST DEMAND FOR LIQUID ENZYMES
8.3 DRY
8.3.1 ENHANCED STABILITY DURING STORAGE AND TRANSPORTATION, SIMPLIFIED ASSAY PROCEDURES, AND REDUCED RISK OF CONTAMINATION TO PROPEL MARKET GROWTH
FIGURE 39 FLOWCHART REPRESENTING PRODUCTION OF DRY ENZYMES
9 SPECIALTY ENZYMES MARKET, BY SOURCE
9.1 INTRODUCTION
FIGURE 40 SPECIALTY ENZYMES MARKET, BY SOURCE, 2024 VS. 2029
TABLE 50 SPECIALTY ENZYMES MARKET, BY SOURCE, 2020–2023 (USD MILLION)
TABLE 51 SPECIALTY ENZYMES MARKET, BY SOURCE, 2024–2029 (USD MILLION)
9.2 MICROORGANISMS
9.2.1 NEED FOR ECONOMIC FEASIBILITY, HIGH YIELDS, CONSISTENCY, AND EASE OF PRODUCT OPTIMIZATION OF SPECIALTY ENZYMES TO BOOST MARKET
TABLE 52 MICROORGANISMS: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
TABLE 53 MICROORGANISMS: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
9.3 PLANTS
9.3.1 ENZYMES DERIVED FROM PLANTS SPEED UP BIOCHEMICAL REACTIONS AND FUNCTION IN ACIDIC ENVIRONMENT
TABLE 54 PLANTS: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
TABLE 55 PLANTS: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
9.4 ANIMALS
9.4.1 ANIMAL-DERIVED ENZYMES FOCUS ON ENHANCING DRUG FORMULATION AND SYNTHESIS PROCESSES
TABLE 56 ANIMALS: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
TABLE 57 ANIMALS: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
10 SPECIALTY ENZYMES MARKET, BY APPLICATION
10.1 INTRODUCTION
FIGURE 41 SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024 VS. 2029
TABLE 58 SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 59 SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
10.2 PHARMACEUTICALS
10.2.1 INCREASING INCORPORATION OF ENZYMES IN THERAPIES TO DRIVE MARKET
TABLE 60 PHARMACEUTICALS: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
TABLE 61 PHARMACEUTICALS: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 62 PHARMACEUTICALS: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 63 PHARMACEUTICALS: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
10.3 RESEARCH & BIOTECHNOLOGY
10.3.1 DROP IN DNA SEQUENCING COSTS AND RISE IN NEW SEQUENCING TECHNIQUES TO BOOST MARKET
TABLE 64 RESEARCH & BIOTECHNOLOGY: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
TABLE 65 RESEARCH & BIOTECHNOLOGY: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 66 RESEARCH & BIOTECHNOLOGY: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 67 RESEARCH & BIOTECHNOLOGY: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
10.4 DIAGNOSTICS
10.4.1 SURGE IN INVESTMENTS AND RISING GERIATRIC POPULATION TO ACCELERATE MARKET GROWTH
TABLE 68 DIAGNOSTICS: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
TABLE 69 DIAGNOSTICS: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 70 DIAGNOSTICS: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 71 DIAGNOSTICS: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
10.5 BIOCATALYSTS
10.5.1 BIODEGRADATION OF PLASTICS BY MICROORGANISMS TO DRIVE DEMAND FOR ENZYMES
TABLE 72 BIOCATALYSTS: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
TABLE 73 BIOCATALYSTS: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 74 BIOCATALYSTS: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 75 BIOCATALYSTS: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11 SPECIALTY ENZYMES MARKET, BY REGION
11.1 INTRODUCTION
FIGURE 42 ASIA PACIFIC TO RECORD HIGHEST GROWTH DURING FORECAST PERIOD
TABLE 76 SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION)
TABLE 77 SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 78 SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (KILOTONS)
TABLE 79 SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (KILOTONS)
11.2 NORTH AMERICA
FIGURE 43 NORTH AMERICAN SPECIALTY ENZYMES MARKET SNAPSHOT
11.2.1 NORTH AMERICA: RECESSION IMPACT ANALYSIS
FIGURE 44 NORTH AMERICA: INFLATION RATES, BY KEY COUNTRY, 2017–2022
FIGURE 45 NORTH AMERICA: RECESSION IMPACT ANALYSIS, 2023
TABLE 80 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
TABLE 81 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 82 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 83 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 84 NORTH AMERICA: CARBOHYDRASES MARKET, BY SUBTYPE, 2020–2023 (USD MILLION)
TABLE 85 NORTH AMERICA: CARBOHYDRASES MARKET, BY SUBTYPE, 2024–2029 (USD MILLION)
TABLE 86 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY SOURCE, 2020–2023 (USD MILLION)
TABLE 87 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY SOURCE, 2024–2029 (USD MILLION)
TABLE 88 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 89 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
11.2.2 US
11.2.2.1 Increasing awareness among manufacturers regarding usage of enzymes for enhanced product quality to drive market
TABLE 90 US: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 91 US: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 92 US: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 93 US: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.2.3 CANADA
11.2.3.1 Rise in cancer cases to lead to increased use of specialty enzymes in diagnostics
TABLE 94 CANADA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 95 CANADA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 96 CANADA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 97 CANADA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.2.4 MEXICO
11.2.4.1 Need for detecting changes in substrate concentrations to boost market growth
TABLE 98 MEXICO: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 99 MEXICO: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 100 MEXICO: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 101 MEXICO: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.3 EUROPE
11.3.1 EUROPE: RECESSION IMPACT ANALYSIS
FIGURE 46 EUROPE: INFLATION RATES, BY KEY COUNTRY, 2017–2022
FIGURE 47 EUROPE: RECESSION IMPACT ANALYSIS, 2023
TABLE 102 EUROPE: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
TABLE 103 EUROPE: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 104 EUROPE: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 105 EUROPE: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 106 EUROPE: CARBOHYDRASES MARKET, BY SUBTYPE, 2020–2023 (USD MILLION)
TABLE 107 EUROPE: CARBOHYDRASES MARKET, BY SUBTYPE, 2024–2029 (USD MILLION)
TABLE 108 EUROPE: SPECIALTY ENZYMES MARKET, BY SOURCE, 2020–2023 (USD MILLION)
TABLE 109 EUROPE: SPECIALTY ENZYMES MARKET, BY SOURCE, 2024–2029 (USD MILLION)
TABLE 110 EUROPE: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 111 EUROPE: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
11.3.2 ITALY
11.3.2.1 Rise in production of pharmaceuticals to drive demand for specialty enzymes
TABLE 112 ITALY: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 113 ITALY: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 114 ITALY: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 115 ITALY: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.3.3 GERMANY
11.3.3.1 Rapid technological advancements in pharmaceuticals sector to boost growth
TABLE 116 GERMANY: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 117 GERMANY: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 118 GERMANY: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 119 GERMANY: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.3.4 FRANCE
11.3.4.1 Clinical developments impacting French biotechnology industry to increase usage of specialty enzymes
TABLE 120 FRANCE: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 121 FRANCE: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 122 FRANCE: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 123 FRANCE: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.3.5 SPAIN
11.3.5.1 Spanish government’s emphasis on developments in pharmaceutical industry to boost enzymes market
TABLE 124 SPAIN: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 125 SPAIN: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 126 SPAIN: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 127 SPAIN: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.3.6 UK
11.3.6.1 Increased use of enzymes in drug cloning technique to spur demand
TABLE 128 UK: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 129 UK: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 130 UK: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 131 UK: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.3.7 DENMARK
11.3.7.1 Growing export of enzymes to propel demand for specialty enzymes
TABLE 132 DENMARK: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 133 DENMARK: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 134 DENMARK: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 135 DENMARK: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.3.8 NETHERLANDS
11.3.8.1 Sustainable lifestyle and demand for environment-friendly products to boost popularity of specialty enzymes
TABLE 136 NETHERLANDS: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 137 NETHERLANDS: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 138 NETHERLANDS: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 139 NETHERLANDS: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.3.9 REST OF EUROPE
TABLE 140 REST OF EUROPE: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 141 REST OF EUROPE: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 142 REST OF EUROPE: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 143 REST OF EUROPE: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.4 ASIA PACIFIC
FIGURE 48 ASIA PACIFIC SPECIALTY ENZYMES MARKET SNAPSHOT
11.4.1 ASIA PACIFIC: RECESSION IMPACT ANALYSIS
FIGURE 49 ASIA PACIFIC: INFLATION RATES, BY KEY COUNTRY, 2017–2022
FIGURE 50 ASIA PACIFIC: RECESSION IMPACT ANALYSIS, 2023
TABLE 144 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
TABLE 145 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 146 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 147 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 148 ASIA PACIFIC: CARBOHYDRASES MARKET, BY SUBTYPE, 2020–2023 (USD MILLION)
TABLE 149 ASIA PACIFIC: CARBOHYDRASES MARKET, BY SUBTYPE, 2024–2029 (USD MILLION)
TABLE 150 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY SOURCE, 2020–2023 (USD MILLION)
TABLE 151 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY SOURCE, 2024–2029 (USD MILLION)
TABLE 152 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 153 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
11.4.2 CHINA
11.4.2.1 Rapid technical advancements to augment demand for specialty enzymes
TABLE 154 CHINA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 155 CHINA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 156 CHINA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 157 CHINA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.4.3 INDIA
11.4.3.1 Rising demand for specialty enzymes in pharmaceutical industry to boost market
TABLE 158 INDIA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 159 INDIA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 160 INDIA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 161 INDIA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.4.4 JAPAN
11.4.4.1 Growing biotechnology advancements in Japan to augment demand for specialty enzymes
TABLE 162 JAPAN: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 163 JAPAN: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 164 JAPAN: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 165 JAPAN: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.4.5 SOUTH KOREA
11.4.5.1 Advancements in biotechnology, medical research, and biopharmaceuticals to boost usage of specialty enzymes
TABLE 166 SOUTH KOREA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 167 SOUTH KOREA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 168 SOUTH KOREA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 169 SOUTH KOREA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.4.6 AUSTRALIA & NEW ZEALAND
11.4.6.1 Favorable government regulations to increase biotechnology advancements and rise in popularity of specialty enzymes
TABLE 170 AUSTRALIA & NEW ZEALAND: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 171 AUSTRALIA & NEW ZEALAND: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 172 AUSTRALIA & NEW ZEALAND: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 173 AUSTRALIA & NEW ZEALAND: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.4.7 REST OF ASIA PACIFIC
TABLE 174 REST OF ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 175 REST OF ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 176 REST OF ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 177 REST OF ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.5 SOUTH AMERICA
11.5.1 SOUTH AMERICA: RECESSION IMPACT
FIGURE 51 SOUTH AMERICA: INFLATION RATES, BY KEY COUNTRY, 2018–2022
FIGURE 52 SOUTH AMERICA: RECESSION IMPACT ANALYSIS, 2023
TABLE 178 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
TABLE 179 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 180 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 181 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 182 SOUTH AMERICA: CARBOHYDRASES MARKET, BY SUBTYPE, 2020–2023 (USD MILLION)
TABLE 183 SOUTH AMERICA: CARBOHYDRASES MARKET, BY SUBTYPE, 2024–2029 (USD MILLION)
TABLE 184 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY SOURCE, 2020–2023 (USD MILLION)
TABLE 185 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY SOURCE, 2024–2029 (USD MILLION)
TABLE 186 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 187 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
11.5.2 BRAZIL
11.5.2.1 Thriving pharmaceutical industry to drive demand for enzymes
TABLE 188 BRAZIL: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 189 BRAZIL: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 190 BRAZIL: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 191 BRAZIL: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.5.3 ARGENTINA
11.5.3.1 Government support in pharmaceuticals and research and development to boost growth
TABLE 192 ARGENTINA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 193 ARGENTINA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 194 ARGENTINA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 195 ARGENTINA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.5.4 REST OF SOUTH AMERICA
TABLE 196 REST OF SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 197 REST OF SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 198 REST OF SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 199 REST OF SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.6 REST OF THE WORLD
11.6.1 REST OF THE WORLD: RECESSION IMPACT ANALYSIS
FIGURE 53 REST OF THE WORLD: INFLATION RATES, BY KEY COUNTRY, 2017–2022
FIGURE 54 REST OF THE WORLD: RECESSION IMPACT ANALYSIS, 2023
TABLE 200 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
TABLE 201 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 202 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 203 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 204 REST OF THE WORLD: CARBOHYDRASES MARKET, BY SUBTYPE, 2020–2023 (USD MILLION)
TABLE 205 REST OF THE WORLD: CARBOHYDRASES MARKET, BY SUBTYPE, 2024–2029 (USD MILLION)
TABLE 206 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY SOURCE, 2020–2023 (USD MILLION)
TABLE 207 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY SOURCE, 2024–2029 (USD MILLION)
TABLE 208 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 209 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
11.6.2 AFRICA
11.6.2.1 Rising demand for generic medicines to boost adoption of specialty enzymes in pharmaceutical industry
TABLE 210 AFRICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 211 AFRICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 212 AFRICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 213 AFRICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
11.6.3 MIDDLE EAST
11.6.3.1 Government initiatives to promote biotechnological research and development to drive demand
TABLE 214 MIDDLE EAST: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
TABLE 215 MIDDLE EAST: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 216 MIDDLE EAST: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION)
TABLE 217 MIDDLE EAST: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION)
